Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultra-low-dose Naloxone for Remifentanil-induced Hyperalgesia
NCT02856087Completed
- Sponsor
- Seoul National University Hospital
- Start
- Nov 2014
- Primary completion
- Apr 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of naloxone in hyperalgesia (3 arms), sponsored by Seoul National University Hospital. Primary endpoint: Mechanical pain thresholds at 24 hours. Started Nov 2014; status: completed.
02
Drugs
naloxone
03
Conditions
hyperalgesia
Beyond the preview
Go deeper on NCT02856087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02856087.